Chapter 9 Viral Strategies to Subvert the Mammalian Translation Machinery

Progress in Molecular Biology and Translational Science

Volumn 90, Issue C, 2009, Pages 313-367

  Roberts, Lisa O ^a   Jopling, Catherine L ^b   Jackson, Richard J ^c   Willis, Anne E ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

4EBP; Frameshifting; IRES; PERK; PKR; Protein synthesis; Reinitiation; Translation; Upstream open reading frame; Virus

Indexed keywords

INITIATION FACTOR 2; VIRUS PROTEIN;

ANIMAL; BIOSYNTHESIS; HOST PATHOGEN INTERACTION; HUMAN; MAMMAL; METABOLISM; PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; VIROLOGY; VIRUS;

ANIMALS; EUKARYOTIC INITIATION FACTOR-2; HOST-PATHOGEN INTERACTIONS; HUMANS; MAMMALS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; VIRAL PROTEINS; VIRUSES;

EID: 77957025367     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)90009-6     Document Type: Review

References (247)

1. La Scola B., Audic S., Robert C., Jungang L., de Lamballerie X., Drancourt M., et al. A giant virus in amoebae. Science 299 (2003) 2033
2. Raoult D., Audic S., Robert C., Abergel C., Renesto P., Ogata H., et al. The 1.2-megabase genome sequence of mimivirus. Science 306 (2004) 1344-1350
3. Sonenberg N., and Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136 (2009) 731-745
4. Lloyd R.E. Translational control by viral proteinases. Virus Res 119 (2006) 76-88
5. Wendel H.G., Silva R.L.A., Malina A., Mills J.R., Zhu H., Ueda T., et al. Dissecting eIF4E action in tumorigenesis. Genes Dev 21 (2007) 3232-3237
6. Bushell M., Wood W., Carpenter G., Pain V.M., Morley S.J., and Clemens M.J. Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages. J Biol Chem 276 (2001) 23922-23928
7. Gebauer F., and Hentze M.W. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 5 (2004) 827-835
8. Jackson R.J., and Standart N. How do microRNAs regulate gene expression?. Sci STKE 2007 (2007) re1
9. Damania B. Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol 2 (2004) 656-668
10. Mohr I. Phosphorylation and dephosphorylation events that regulate viral mRNA translation. Virus Res 119 (2006) 89-99
11. Walsh D., Perez C., Notary J., and Mohr I. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J Virol 79 (2005) 8057-8064
12. Clemens M.J. Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation. Int J Biochem Cell Biol 38 (2006) 164-169
13. Kudchodkar S.B., Yu Y.J., Maguire T.G., and Alwine J.C. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J Virol 78 (2004) 11030-11039
14. Wang F.Z., Weber F., Croce C., Liu C.G., Liao X., and Pellett P.E. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol 82 (2008) 9065-9074
15. Arias C., Walsh D., Harbell J., Wilson A.C., and Mohr I. Activation of host translational control pathways by a viral developmental switch. PLoS Pathog 5 (2009) e1000334
16. Martin S.A., and Moss B. Modification of RNA by messenger-RNA guanylyltransferase and messenger-RNA (guanine-7-)methyltransferase from vaccinia virions. J Biol Chem 250 (1975) 9330-9335
17. Walsh D., and Mohr I. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev 18 (2004) 660-672
18. O'Shea C.C., Choi S., McCormick F., and Stokoe D. Adenovirus overrides cellular checkpoints for protein translation. Cell Cycle 4 (2005) 883-888
19. Gingras A.C., Svitkin Y., Belsham G.J., Pause A., and Sonenberg N. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc Natl Acad Sci USA A93 (1996) 5578-5583
20. Beretta L., Svitkin Y.V., and Sonenberg N. Rapamycin stimulates viral protein synthesis and augments the shutoff of host protein synthesis upon picornavirus infection. J Virol 70 (1996) 8993-8996
21. Connor J.H., and Lyles D.S. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1. J Virol 76 (2002) 10177-10187
22. Kneller E.L.P., Connor J.H., and Lyles D.S. hnRNPs relocalize to the cytoplasm following infection with vesicular stomatitis virus. J Virol 83 (2009) 770-780
23. Gingras A.C., Raught B., and Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68 (1999) 913-963
24. Fukunaga R., and Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16 (1997) 1921-1933
25. Waskiewicz A.J., Flynn A., Proud C.G., and Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 16 (1997) 1909-1920
26. Wells S.E., Hillner P.E., Vale R.D., and Sachs A.B. Circularization of mRNA by eukaryotic translation initiation factors. Mol Cell 2 (1998) 135-140
27. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., and Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454 (2008) 780-783
28. Scheper G.C., and Proud C.G. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation?. Eur J Biochem 269 (2002) 5350-5359
29. Willcocks M.M., Carter M.J., and Roberts L.O. Cleavage of eukaryotic initiation factor eIF4G and inhibition of host-cell protein synthesis during feline calicivirus infection. J Gen Virol 85 (2004) 1125-1130
30. Riley D., and Flint S.J. RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein. J Virol 67 (1993) 3586-3595
31. Cuesta R., Xi Q.R., and Schneider R.J. Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex elF4F. EMBO J 19 (2000) 3465-3474
32. Zhao Y., Yao Y., Xu H., Lambeth L., Smith L.P., Kgosana L., et al. A functional microRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol 83 (2009) 489-492
33. Xia T., O'Hara A., Araujo I., Barreto J., Carvalho E., Sapucaia J.B., et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68 (2008) 1436-1442
34. Feigenblum D., and Schneider R.J. Modification of eukaryotic initiation-factor 4F during infection by influenza-virus. J Virol 67 (1993) 3027-3035
35. Etchison D., Milburn S.C., Edery I., Sonenberg N., and Hershey J.W. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257 (1982) 14806-14810
36. Lamphear B.J., Kirchweger R., Skern T., and Rhoads R.E. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem 270 (1995) 21975-21983
37. Lamphear B.J., Yan R., Yang F., Waters D., Liebig H.D., Klump H., et al. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J Biol Chem 268 (1993) 19200-19203
38. Gradi A., Foeger N., Strong R., Svitkin Y.V., Sonenberg N., Skern T., et al. Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the L-protease cleavage site in vitro. J Virol 78 (2004) 3271-3278
39. Sullivan C.S., Grundhoff A.T., Tevethia S., Pipas J.M., and Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435 (2005) 682-686
40. Perez L., and Carrasco L. Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection. Virology 189 (1992) 178-186
41. Gradi A., Svitkin Y.V., Imataka H., and Sonenberg N. Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci USA A95 (1998) 11089-11094
42. Ali I.K., McKendrick L., Morley S.J., and Jackson R.J. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G. J Virol 75 (2001) 7854-7863
43. Pestova T.V., Shatsky I.N., and Hellen C.U. Functional dissection of eukaryotic initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes. Mol Cell Biol 16 (1996) 6870-6878
44. Wilson J.E., Pestova T.V., Hellen C.U., and Sarnow P. Initiation of protein synthesis from the A site of the ribosome. Cell 102 (2000) 511-520
45. Goodfellow I., Chaudhry Y., Gioldasi I., Gerondopoulos A., Natoni A., Labrie L., et al. Calicivirus translation initiation requires an interaction between VPg and eIF4E. EMBO Rep 6 (2005) 968-972
46. Chaudhry Y., Nayak A., Bordeleau M.E., Tanaka J., Pelletier J., Belsham G.J., et al. Caliciviruses differ in their functional requirements for eIF4F components. J Biol Chem 281 (2006) 25315-25325
47. Ohlmann T., Prevot D., Decimo D., Roux F., Garin J., Morley S.J., et al. In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system. J Mol Biol 318 (2002) 9-20
48. Ventoso I., Sanz M.A., Molina S., Berlanga J.J., Carrasco L., and Esteban M. Translational resistance of late alphavirus mRNA to eIF2 alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR. Genes Dev 20 (2006) 87-100
49. Alvarez E., Menendez-Arias L., and Carrasco L. The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J Virol 77 (2003) 12392-12400
50. Joachims M., Van Breugel P.C., and Lloyd R.E. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73 (1999) 718-727
51. Kerekatte V., Keiper B.D., Badorff C., Cai A.L., Knowlton K.U., and Rhoads R.E. Cleavage of poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff ?. J Virol 73 (1999) 709-717
52. Mangus D.A., Evans M.C., and Jacobson A. Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol 4 (2003) 14
53. Mullin C., Duning K., Barnekow A., Richter D., Kremerskothen J., and Mohr E. Interaction of rat poly(A)-binding protein with poly(A)- and non-poly(A) sequences is preferentially mediated by RNA recognition motifs 3 + 4. FEBS Lett 576 (2004) 437-441
54. Kuyumcu-Martinez M., Belliot G., Sosnovtsev S.V., Chang K.O., Green K.Y., and Lloyd R.E. Calicivirus 3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein. J Virol 78 (2004) 8172-8182
55. Bergamini G., Preiss T., and Hentze M.W. Picornavirus IRESes and the poly(A) tail jointly promote cap-independent translation in a mammalian cell-free system. RNA 6 (2000) 1781-1790
56. Michel Y.M., Borman A.M., Paulous S., and Kean K.M. Eukaryotic initiation factor 4G-poly(A) binding protein interaction is required for poly(A) tail-mediated stimulation of picornavirus internal ribosome entry segment-driven translation but not for X-mediated stimulation of hepatitis C virus translation. Mol Cell Biol 21 (2001) 4097-4109
57. Zhang Y., Feigenblum D., and Schneider R.J. A late adenovirus factor induces eIF-4e dephosphorylation and inhibition of cell protein-synthesis. J Virol 68 (1994) 7040-7050
58. Bonderoff J.M., Larey J.L., and Lloyd R.E. Cleavage of poly(A)-binding protein by poliovirus 3C proteinase inhibits viral internal ribosome entry site-mediated translation. J Virol 82 (2008) 9389-9399
59. Ilkow C.S., Mancinelli V., Beatch M.D., and Hobman T.C. Rubella virus capsid protein interacts with poly(A)-binding protein and inhibits translation. J Virol 82 (2008) 4284-4294
60. Imai M., Akatani K., Ikegami N., and Furuichi Y. Capped and conserved terminal structures in human rotavirus genome double-stranded-RNA segments. J Virol 47 (1983) 125-136
61. Piron M., Vende P., Cohen J., and Poncet D. Rotavirus RNA-binding protein NSP3 interacts with eIF4GI and evicts the poly(A) binding protein from eIF4F. EMBO J 17 (1998) 5811-5821
62. Montero H., Arias C.F., and Lopez S. Rotavirus nonstructural protein NSP3 is not required for viral protein synthesis. J Virol 80 (2006) 9031-9038
63. Blakqori G., van Knippenberg I., and Elliott R.M. Bunyamwera Orthobunyavirus S-segment untranslated regions mediate poly(A) tail-independent translation. J Virol 83 (2009) 3637-3646
64. Chiu W.W., Kinney R.M., and Dreher T.W. Control of translation by the 5′- and 3′-terminal regions of the dengue virus genome. J Virol 79 (2005) 8303-8315
65. Jang S.K., Krausslich H.G., Nicklin M.J., Duke G.M., Palmenberg A.C., and Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62 (1988) 2636-2643
66. Pelletier J., and Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334 (1988) 320-325
67. Jackson R.J., and Kaminski A. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1 (1995) 985-1000
68. Kolupaeva V.G., Lomakin I.B., Pestova T.V., and Hellen C.U. Eukaryotic initiation factors 4G and 4A mediate conformational changes downstream of the initiation codon of the encephalomyocarditis virus internal ribosomal entry site. Mol Cell Biol 23 (2003) 687-698
69. de Breyne S., Yu Y.P., Unbehaun A., Pestova T.V., and Hellen C.U.T. Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sites. Proc Natl Acad Sci USA A106 (2009) 9197-9202
70. Hunt S.L., and Jackson R.J. Polypyrimidine-tract binding protein (PTB) is necessary, but not sufficient, for efficient internal initiation of translation of human rhinovirus-2 RNA. RNA 5 (1999) 344-359
71. Florez P.M., Sessions O.M., Wagner E.J., Gromeier M., and Garcia-Blanco M.A. The polypyrimidine tract binding protein is required for efficient picornavirus gene expression and propagation. J Virol 79 (2005) 6172-6179
72. Costa-Mattioli M., Svitkin Y., and Sonenberg N. La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol Cell Biol 24 (2004) 6861-6870
73. Pilipenko E.V., Pestova T.V., Kolupaeva V.G., Khitrina E.V., Poperechnaya A.N., Agol V.I., et al. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev 14 (2000) 2028-2045
74. Monie T.P., Perrin A.J., Birtley J.R., Sweeney T.R., Karakasiliotis I., Chaudhry Y., et al. Structural insights into the transcriptional and translational roles of Ebp1. EMBO J 26 (2007) 3936-3944
75. Roberts L.O., Seamons R.A., and Belsham G.J. Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins. RNA 4 (1998) 520-529
76. Dobrikova E.Y., Grisham R.N., Kaiser C., Lin J., and Gromeier M. Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors. J Virol 80 (2006) 3310-3321
77. Kaku Y., Chard L.S., Inoue T., and Belsham G.J. Unique characteristics of a picornavirus internal ribosome entry site from the porcine teschovirus-1 talfan. J Virol 76 (2002) 11721-11728
78. Bakhshesh M., Groppelli E., Willcocks M.A., Royall E., Belsham G.J., and Roberts L.O. The picornavirus avian encephalomyelitis virus possesses a hepatitis C virus-like internal ribosome entry site element. J Virol 82 (2008) 1993-2003
79. Pisarev A.V., Chard L.S., Kaku Y., Johns H.L., Shatsky I.N., and Belsham G.J. Functional and structural similarities between the internal ribosome entry sites of hepatitis C virus and porcine teschovirus, a picornavirus. J Virol 78 (2004) 4487-4497
80. Brown E.A., Zhang H., Ping L.H., and Lemon S.M. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20 (1992) 5041-5045
81. Ueda T., Watanabe-Fukunaga R., Fukuyama H., Nagata S., and Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24 (2004) 6539-6549
82. Pestova T.V., Shatsky I.N., Fletcher S.P., Jackson R.J., and Hellen C.U. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 12 (1998) 67-83
83. Lancaster A.M., Jan E., and Sarnow P. Initiation factor-independent translation mediated by the hepatitis C virus internal ribosome entry site. RNA 12 (2006) 894-902
84. Thompson S.R., Gulyas K.D., and Sarnow P. Internal initiation in Saccharomyces cerevisiae mediated by an initiator tRNA/eIF2-independent internal ribosome entry site element. Proc Natl Acad Sci USA 98 (2001) 12972-12977
85. Spahn C.M., Kieft J.S., Grassucci R.A., Penczek P.A., Zhou K., Doudna J.A., et al. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 291 (2001) 1959-1962
86. Passmore L.A., Schmeing T.M., Maag D., Applefield D.J., Acker M.G., Algire M.A., et al. The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosome. Mol Cell 26 (2007) 41-50
87. Fraser C.S., Hershey J.W., and Doudna J.A. The pathway of hepatitis C virus mRNA recruitment to the human ribosome. Nat Struct Mol Biol 16 (2009) 397-404
88. Otto G.A., and Puglisi J.D. The pathway of HCV IRES-mediated translation initiation. Cell 119 (2004) 369-380
89. Locker N., Easton L.E., and Lukavsky P.J. HCV and CSFV IRES domain II mediate eIF2 release during 80S ribosome assembly. EMBO J 26 (2007) 795-805
90. Sasaki J., and Nakashima N. Translation initiation at the CUU codon is mediated by the internal ribosome entry site of an insect picorna-like virus in vitro. J Virol 73 (1999) 1219-1226
91. Woolaway K.E., Lazaridis K., Belsham G.J., Carter M.J., and Roberts L.O. The 5′ untranslated region of Rhopalosiphum padi virus contains an internal ribosome entry site which functions efficiently in mammalian, plant, and insect translation systems. J Virol 75 (2001) 10244-10249
92. Jan E., and Sarnow P. Factorless ribosome assembly on the internal ribosome entry site of cricket paralysis virus. J Mol Biol 324 (2002) 889-902
93. Jan E., Kinzy T.G., and Sarnow P. Divergent tRNA-like element supports initiation, elongation, and termination of protein biosynthesis. Proc Natl Acad Sci USA 100 (2003) 15410-15415
94. Pestova T.V., and Hellen C.U. Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA. Genes Dev 17 (2003) 181-186
95. Costantino D.A., Pfingsten J.S., Rambo R.P., and Kieft J.S. tRNA-mRNA mimicry drives translation initiation from a viral IRES. Nat Struct Mol Biol 15 (2008) 57-64
96. Spahn C.M., Jan E., Mulder A., Grassucci R.A., Sarnow P., and Frank J. Cryo-EM visualization of a viral internal ribosome entry site bound to human ribosomes: the IRES functions as an RNA-based translation factor. Cell 118 (2004) 465-475
97. Deniz N., Lenarcic E.M., Landry D.M., and Thompson S.R. Translation initiation factors are not required for Dicistroviridae IRES function in vivo. RNA 15 (2009) 932-946
98. Triboulet R., Mari B., Lin Y.L., Chable-Bessia C., Bennasser Y., Lebrigand K., et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315 (2007) 1579-1582
99. Terenin I.M., Dmitriev S.E., Andreev D.E., and Shatsky I.N. Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2. Nat Struct Mol Biol 15 (2008) 836-841
100. Xi Q.R., Cuesta R., and Schneider R.J. Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting. Genes Dev 18 (2004) 1997-2009
101. Buck C.B., Shen X., Egan M.A., Pierson T.C., Walker C.M., and Siliciano R.F. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J Virol 75 (2001) 181-191
102. Brasey A., Lopez-Lastra M., Ohlmann T., Beerens N., Berkhout B., Darlix J.L., et al. The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J Virol 77 (2003) 3939-3949
103. Herbreteau C.H., Weill L., Decimo D., Prevot D., Darlix J.L., Sargueil B., et al. HIV-2 genomic RNA contains a novel type of IRES located downstream of its initiation codon. Nat Struct Mol Biol 12 (2005) 1001-1007
104. Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., et al. Identification of virus-encoded microRNAs. Science 304 (2004) 734-736
105. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2 (2005) 269-276
106. Seo G.J., Fink L.H., O'Hara B., Atwood W.J., and Sullivan C.S. Evolutionarily conserved function of a viral microRNA. J Virol 82 (2008) 9823-9828
107. Sullivan C.S., Sung C.K., Pack C.D., Grundhoff A., Lukacher A.E., Benjamin T.L., et al. Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection. Virology 387 (2009) 157-167
108. Takyar S., Hickerson R.P., and Noller H.F. MRNA helicase activity of the ribosome. Cell 120 (2005) 49-58
109. Xuan B.Q., Qian Z.K., Torigoi E., and Yu D. Human cytomegalovirus protein pul38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J Virol 83 (2009) 3463-3474
110. Ouellet D.L., Plante I., Landry P., Barat C., Janelle M.E., Flamand L., et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 36 (2008) 2353-2365
111. Lin J., and Cullen B.R. Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol 81 (2007) 12218-12226
112. Grundhoff A., Sullivan C.S., and Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12 (2006) 733-750
113. Cai X., Schafer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2 (2006) e23
114. Ventoso I., Blanco R., Perales C., and Carrasco L. HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc Natl Acad Sci USA 98 (2001) 12966-12971
115. Seo G.J., Chen C.J., and Sullivan C.S. Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology 383 (2009) 183-187
116. Murphy E., Vanicek J., Robins H., Shenk T., and Levine A.J. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci USA 105 (2008) 5453-5458
117. Xu N., Segerman B., Zhou X., and Akusjarvi G. Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the RNA-induced silencing complex and associate with polyribosomes. J Virol 81 (2007) 10540-10549
118. Choy E.Y., Siu K.L., Kok K.H., Lung R.W., Tsang C.M., To K.F., et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205 (2008) 2551-2560
119. Samols M.A., Skalsky R.L., Maldonado A.M., Riva A., Lopez M.C., Baker H.V., et al. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3 (2007) e65
120. Nachmani D., Stern-Ginossar N., Sarid R., and Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5 (2009) 376-385
121. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450 (2007) 1096-1099
122. Ylosmaki E., Hakkarainen T., Hemminki A., Visakorpi T., Andino R., and Saksela K. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J Virol 82 (2008) 11009-11015
123. Ziegelbauer J.M., Sullivan C.S., and Ganem D. Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet 41 (2009) 130-134
124. Cameron J.E., Fewell C., Yin Q., McBride J., Wang X., Lin Z., et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 382 (2008) 257-266
125. Godshalk S.E., Bhaduri-McIntosh S., and Slack F.J. Epstein-Barr virus-mediated dysregulation of human microRNA expression. Cell Cycle 7 (2008) 3595-3600
126. Wang X.M., Flynn A., Waskiewicz A.J., Webb B.L.J., Vries R.G., Baines I.A., et al. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 273 (1998) 9373-9377
127. Tsukiyama-Kohara K., Iizuka N., Kohara M., and Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 66 (1992) 1476-1483
128. Lu S., and Cullen B.R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J Virol 78 (2004) 12868-12876
129. Bennasser Y., Le S.Y., Benkirane M., and Jeang K.T. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22 (2005) 607-619
130. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., et al. A cellular microRNA mediates antiviral defense in human cells. Science 308 (2005) 557-560
131. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., and Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309 (2005) 1577-1581
132. Henke J.I., Goergen D., Zheng J., Song Y., Schuttler C.G., Fehr C., et al. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27 (2008) 3300-3310
133. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449 (2007) 919-922
134. Kelly E.J., Hadac E.M., Greiner S., and Russell S.J. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 14 (2008) 1278-1283
135. Yuan P.W., Bartlam M., Lou Z.Y., Chen S.D., Zhou J., He X.J., et al. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 458 (2009) 909-913
136. Daughenbaugh K.F., Fraser C.S., Hershey J.W.B., and Hardy M.E. The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. EMBO J 22 (2003) 2852-2859
137. Dreher T.W., and Miller W.A. Translational control in positive strand RNA plant viruses. Virology 344 (2006) 185-197
138. Leonard S., Plante D., Wittmann S., Daigneault N., Fortin M.G., and Laliberte J.F. Complex formation between potyvirus VPg and translation eukaryotic initiation factor 4E correlates with virus infectivity. J Virol 74 (2000) 7730-7737
139. Garfinkel M.S., and Katze M.G. How does influenza virus regulate gene expression at the level of mRNA translation? Let us count the ways. Gene Expr 3 (1993) 109-118
140. Shih S.R., and Krug R.M. Surprising function of the three influenza viral polymerase proteins: selective protection of viral mRNAs against the cap-snatching reaction catalyzed by the same polymerase proteins. Virology 226 (1996) 430-435
141. Dias A., Bouvier D., Crepin T., McCarthy A.A., Hart D.J., Baudin F., et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458 (2009) 914-918
142. Yue Z.Y., and Shatkin A.J. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. Virology 234 (1997) 364-371
143. Burgui I., Yanguez E., Sonenberg N., and Nieto A. Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation?. J Virol 81 (2007) 12427-12438
144. Mir M.A., and Panganiban A.T. A protein that replaces the entire cellular eIF4F complex. EMBO J 27 (2008) 3129-3139
145. Mir M.A., and Panganiban A.T. Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein. J Virol 80 (2006) 6276-6285
146. Brierley I., and Dos Ramos F.J. Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV. Virus Res 119 (2006) 29-42
147. Brierley I., Digard P., and Inglis S.C. Characterization of an efficient coronavirus ribosomal frameshifting signal-requirement for an RNA pseudoknot. Cell 57 (1989) 537-547
148. Gaudin C., Mazauric M.H., Traikia M., Guittet E., Yoshizawa S., and Fourmy D. Structure of the RNA signal essential for translational frameshifting in HIV-1. J Mol Biol 349 (2005) 1024-1035
149. Kollmus H., Honigman A., Panet A., and Hauser H. The sequences of and distance between 2 cis-acting signals determine the efficiency of ribosomal frameshifting in human-immunodeficiency-virus type-1 and human T-cell leukemia-virus type-II in-vivo. J Virol 68 (1994) 6087-6091
150. Giedroc D.P., and Cornish P.V. Frameshifting RNA pseudoknots: structure and mechanism. Virus Res 139 (2009) 193-208
151. Jacks T., Madhani H.D., Masiarz F.R., and Varmus H.E. Signals for ribosomal frameshifting in the rous-sarcoma virus gag-pol region. Cell 55 (1988) 447-458
152. Namy O., Moran S.J., Stuart D.I., Gilbert R.J.C., and Brierley I. A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting. Nature 441 (2006) 244-247
153. Brierley I., Rolley N.J., Jenner A.J., and Inglis S.C. Mutational analysis of the RNA pseudoknot component of a coronavirus ribosomal frameshifting signal. J Mol Biol 220 (1991) 889-902
154. Brierley I., Jenner A.J., and Inglis S.C. Mutational analysis of the slippery-sequence component of a coronavirus ribosomal frameshifting signal. J Mol Biol 227 (1992) 463-479
155. Terenin I.M., Dmitriev S.E., Andreev D.E., Royall E., Belsham G.J., Roberts L.O., et al. A cross-kingdom internal ribosome entry site reveals a simplified mode of internal ribosome entry. Mol Cell Biol 25 (2005) 7879-7888
156. Drosten C. Presented at the 6th Asia Pacific Congress of Medical Virology (2003), Kuala Lumpur, Malaysia
157. Baranov P.V., Henderson C.M., Anderson C.B., Gesteland R.F., Atkins J.F., and Howard M.T. Programmed ribosomal frameshifting in decoding the SARS-CoV genome. Virology 332 (2005) 498-510
158. Plant E.P., Perez-Alvarado G.C., Jacobs J.L., Mukhopadhyay B., Hennig M., and Dinman J.D. A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal. PLoS Biol 3 (2005) e172
159. Brierley I., Gilbert R.J.C., and Pennell S. RNA pseudoknots and the regulation of protein synthesis. Biochem Soc Trans 36 (2008) 684-689
160. Cen S., Niu M.J., Saadatmand J., Guo F., Huang Y., Nabel G.J., et al. Incorporation of Pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-Pol. J Virol 78 (2004) 1042-1049
161. Shehu-Xhilaga M., Crowe S.M., and Mak J. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J Virol 75 (2001) 1834-1841
162. Biswas P., Jiang X., Pacchia A.L., Dougherty J.P., and Peltz S.W. The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol 78 (2004) 2082-2087
163. Marcheschi R.J., Staple D.W., and Butcher S.E. Programmed ribosomal frameshifting is SIV is induced by a highly structured RNA stem-loop. J Mol Biol 373 (2007) 652-663
164. Staple D.W., and Butcher S.E. Pseudoknots: RNA structures with diverse functions. PLoS Biol 3 (2005) e213
165. Staple D.W., and Butcher S.E. Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element. J Mol Biol 349 (2005) 1011-1023
166. Stojdl D.F., Abraham N., Knowles S., Marius R., Brasey A., Lichty B.D., et al. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol 74 (2000) 9580-9585
167. Gareiss P.C., and Miller B.L. Ribosomal frameshifting: an emerging drug target for HIV. Curr Opin Investig Drugs 10 (2009) 121-128
168. Kozak M. Effects of intercistronic length on the efficiency of reinitiation by eukaryotic ribosomes. Mol Cell Biol 7 (1987) 3438-3445
169. Kontos H., Napthine S., and Brierley I. Ribosomal pausing at a frameshifter RNA pseudoknot is sensitive to reading phase but shows little correlation with frameshift efficiency. Mol Cell Biol 21 (2001) 8657-8670
170. Kozak M. Constraints on reinitiation of translation in mammals. Nucleic Acids Res 29 (2001) 5226-5232
171. Somogyi P., Jenner A.J., Brierley I., and Inglis S.C. Ribosomal pausing during translation of an RNA pseudoknot. Mol Cell Biol 13 (1993) 6931-6940
172. Poyry T.A.A., Kaminski A., and Jackson R.J. What determines whether mammalian ribosomes resume scanning after translation of a short upstream open reading frame?. Genes Dev 18 (2004) 62-75
173. Meyers G. Characterization of the sequence element directing translation reinitiation in RNA of the calicivirus, rabbit hemorrhagic disease virus. J Virol 81 (2007) 9623-9632
174. Meyers G. Translation of the minor capsid protein of a calicivirus is initiated by a novel termination-dependent reinitiation mechanism. J Biol Chem 278 (2003) 34051-34060
175. Luttermann C., and Meyers G. The importance of inter- and intramolecular base pairing for translation reinitiation on a eukaryotic bicistronic mRNA. Genes Dev 23 (2009) 331-344
176. Poyry T.A.A., Kaminski A., Connell E.J., Fraser C.S., and Jackson R.J. The mechanism of an exceptional case of reinitiation after translation of a long ORF reveals why such events do not generally occur in mammalian mRNA translation. Genes Dev 21 (2007) 3149-3162
177. Pisarev A.V., Hellen C.U., and Pestova T.V. Recycling of eukaryotic posttermination ribosomal complexes. Cell 131 (2007) 286-299
178. Jackson D., Zurcher T., and Barclay W. Reduced incorporation of the influenza B virus BM2 protein in virus particles decreases infectivity. Virology 322 (2004) 276-285
179. Horvath C.M., Williams M.A., and Lamb R.A. Eukaryotic coupled translation of tandem cistrons-identification of the influenza-b virus bm2 polypeptide. EMBO J 9 (1990) 2639-2647
180. Powell M.L., Napthine S., Jackson R.J., Brierley I., and Brown T.D.K. Characterization of the termination-reinitiation strategy employed in the expression of influenza B virus BM2 protein. RNA 14 (2008) 2394-2406
181. Powell M.L., Brown T.D.K., and Brierley I. Translational termination-re-initiation in viral systems. Biochem Soc Trans 36 (2008) 717-722
182. Easton A.J., Domachowske J.B., and Rosenberg H.F. Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev 17 (2004) 390-412
183. Ahmadian G., Randhawa J.S., and Easton A.J. Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism. EMBO J 19 (2000) 2681-2689
184. Gould P.S., and Easton A.J. Coupled translation of the respiratory syncytial virus M2 open reading frames requires upstream sequences. J Biol Chem 280 (2005) 21972-21980
185. Gould P.S., and Easton A.J. Coupled translation of the second open reading frame of M2 mRNA is sequence dependent and differs significantly within the subfamily Pneumovirinae. J Virol 81 (2007) 8488-8496
186. Russell W.C. Adenoviruses: update on structure and function. J Gen Virol 90 (2009) 1-20
187. Berget S.M., Moore C., and Sharp P.A. Spliced segments at 5′ terminus of adenovirus 2 late messenger-RNA. Proc Natl Acad Sci USA A74 (1977) 3171-3175
188. Moore C.L., Skolnikdavid H., and Sharp P.A. Analysis of RNA cleavage at the adenovirus-2 l3 polyadenylation site. EMBO J 5 (1986) 1929-1938
189. Yueh A., and Schneider R.J. Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev 14 (2000) 414-421
190. Zhang B., Seitz S., Kusov Y., Zell R., and Gauss-Muller V. RNA interaction and cleavage of poly(C)-binding protein 2 by hepatitis A virus protease. Biochem Biophys Res Commun 364 (2007) 725-730
191. Shmulevitz M., Marcato P., and Lee P.W.K. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer. Oncogene 24 (2005) 7720-7728
192. Costas C., Martinez-Costas J., Bodelon G., and Benavente J. The second open reading frame of the avian reovirus S1 gene encodes a transcription-dependent and CRM1-independent nucleocytoplasmic shuttling protein. J Virol 79 (2005) 2141-2150
193. Grande A., Rodriguez E., Costas C., Everitt E., and Benavente J. Oligomerization and cell-binding properties of the avian reovirus cell-attachment protein sigma C. Virology 274 (2000) 367-377
194. Racine T., Barry C., Roy K., Dawe S.J., Shmulevitz M., and Duncan R. Leaky scanning and scanning-independent ribosome migration on the tricistronic S1 mRNA of avian reovirus*. J Biol Chem 282 (2007) 25613-25622
195. Latorre P., Kolakofsky D., and Curran J. Sendai virus Y proteins are initiated by a ribosomal shunt. Mol Cell Biol 18 (1998) 5021-5031
196. Curran J., and Kolakofsky D. Replication of paramyxoviruses. Adv Virus Res 54 (1999) 403-422
197. Curran J., and Kolakofsky D. Scanning independent ribosomal initiation of the sendai virus-Y proteins in vitro and in vivo. EMBO J 8 (1989) 521-526
198. Curran J., and Kolakofsky D. Scanning independent ribosomal initiation of the Sendai virus X-protein. EMBO J 7 (1988) 2869-2874
199. de Breyne S., Stalder R., and Curran J. Intracellular processing of the Sendai virus C′ protein leads to the generation of a Y protein module: structure-functional implications. FEBS Lett 579 (2005) 5685-5690
200. Doronina V.A., de Felipe P., Wu C., Sharma P., Sachs M.S., Ryan M.D., et al. Dissection of a co-translational nascent chain separation event. Biochem Soc Trans 36 (2008) 712-716
201. Doronina V.A., Wu C., de Felipe P., Sachs M.S., Ryan M.D., and Brown J.D. Site-specific release of nascent chains from ribosomes at a sense codon. Mol Cell Biol 28 (2008) 4227-4239
202. Meurs E., Chong K.L., Galabru J., Thomas N.S.B., Kerr I.M., Williams B.R.G., et al. Molecular cloning and characterisation of the human double-stranded RNA-dependent protein kinase induced by interferon. Cell 62 (1990) 379-390
203. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnaik A.K., Archer D.R., et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 (2000) 129-141
204. Galabru J., and Hovanessian A. Autophosphorylation of the protein-kinase dependent on double-stranded-RNA. J Biol Chem 262 (1987) 15538-15544
205. Strong R., and Belsham G.J. Sequential modification of translation initiation factor elF4GI by two different foot-and-mouth disease virus proteases within infected baby hamster kidney cells: identification of the 3C(pro) cleavage site. J Gen Virol 85 (2004) 2953-2962
206. Burysek L., and Pitha P.M. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 75 (2001) 2345-2352
207. Pavio N., Taylor D.R., and Lai M.M.C. Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J Virol 76 (2002) 1265-1272
208. Gale M., Tan S.L., Wambach M., and Katze M.G. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins p58(IPK) and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation. Mol Cell Biol 16 (1996) 4172-4181
209. Gale M.J., Korth M.J., Tang N.M., Tan S.L., Hopkins D.A., Dever T.E., et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230 (1997) 217-227
210. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis-c virus 1b-sensitivity to interferon is conferred by amino-acid substitutions in the NS5a region. J Clin Invest 96 (1995) 224-230
211. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334 (1996) 77-81
212. Kmieciak D., Kruszyna L., Migdalski P., Lacinski M., Juszczyk J., and Trzeciak W.H. Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment. Jap J Infect Dis 59 (2006) 92-99
213. De Mitri M.S., Cassini R., Bagaglio S., Morsica G., Andreone P., Marino N., et al. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma. Liver Int 27 (2007) 1126-1133
214. De Mitri M.S., Morsica G., Cassini R., Bagaglio S., Zoli M., Alberti A., et al. Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma. J Hepatol 36 (2002) 116-122
215. Gimenez-Barcons M., Wang C.F., Chen M., Sanchez-Tapias J.M., Saiz J.C., and Gale M. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation. J Interferon Cytokine Res 25 (2005) 152-164
216. Muesing M.A., Smith D.H., and Capon D.J. Regulation of messenger-RNA accumulation by a human-immunodeficiency-virus transactivator protein. Cell 48 (1987) 691-701
217. Roy S., Agy M., Hovanessian A.G., Sonenberg N., and Katze M.G. The integrity of the stem structure of human-immunodeficiency-virus type-1 tat-responsive sequence RNA is required for interaction with the interferon-induced 68,000-MR protein-kinase. J Virol 65 (1991) 632-640
218. Gunnery S., Rice A.P., Robertson H.D., and Mathews M.B. Tat-responsive region RNA of human immunodeficiency virus-1 can prevent activation of the double-stranded-RNA-activated protein-kinase. Proc Natl Acad Sci USA A87 (1990) 8687-8691
219. Roy S., Katze M.G., Parkin N.T., Edery I., Hovanessian A.G., and Sonenberg N. Control of the interferon-induced 68-kilodalton protein-kinase by the HIV-1 tat gene-product. Science 247 (1990) 1216-1219
220. Brand S.R., Kobayashi R., and Mathews M.B. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J Biol Chem 272 (1997) 8388-8395
221. McMillan N.A.J., Chun R.F., Siderovski D.P., Galabru J., Toone W.M., Samuel C.E., et al. Hiv-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213 (1995) 413-424
222. Endo-Munoz L., Warby T., Harrich D., and McMillan N.A.J. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virol J 2 (2005) 17
223. Carroll K., Elroystein O., Moss B., and Jagus R. Recombinant vaccinia virus k3l gene-product prevents activation of double-stranded RNA-dependent, initiation factor-2-alpha-specific protein-kinase. J Biol Chem 268 (1993) 12837-12842
224. Beattie E., Paoletti E., and Tartaglia J. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3l(-) and E3l(-) mutant viruses. Virology 210 (1995) 254-263
225. Sharp T.V., Schwemmle M., Jeffrey I., Laing K., Mellor H., Proud C.G., et al. Comparative-analysis of the regulation of the interferon-inducible protein-kinase PKR by Epstein-Barr-virus RNAs Eber-1 and Eber-2 and adenovirus VA(I) RNA. Nucleic Acids Res 21 (1993) 4483-4490
226. Nanbo A., and Yoshiyama H. Epstein-Barr virus-encoded poly(A)(-) RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. J Virol 79 (2005) 12280-12285
227. Katze M.G., De Corato D., Safer B., Galabru J., and Hovanessian A. Adenovirus VAI RNA complexes with the 68,000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J 6 (1987) 689-697
228. Davies M.V., Chang H.W., Jacobs B.L., and Kaufman R.J. The E3l and K3l vaccinia virus gene-products stimulate translation through inhibition of the double-stranded RNA-dependent protein-kinase by different mechanisms. J Virol 67 (1993) 1688-1692
229. Yueh A., and Schneider R.J. Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells. Genes Dev 10 (1996) 1557-1567
230. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., and Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res 119 (2006) 100-110
231. Lu Y., Wambach M., Katze M.G., and Krug R.M. Binding of the influenza-virus ns1 protein to double-stranded-RNA inhibits the activation of the protein-kinase that phosphorylates the eIF-2 translation initiation-factor. Virology 214 (1995) 222-228
232. Shors T., Kibler K.V., Perkins K.B., Seidler-Wulff R., Banaszak M.P., and Jacobs B.L. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. Virology 239 (1997) 269-276
233. Khoo D., Perez C., and Mohr I. Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation. J Virol 76 (2002) 11971-11981
234. Poppers J., Mulvey M., Perez C., Khoo D., and Mohr I. Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J Virol 77 (2003) 228-236
235. Cassady K.A., and Gross M. The herpes simplex virus type 1 U(s)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain. J Virol 76 (2002) 2029-2035
236. Black T.L., Safer B., Hovanessian A., and Katze M.G. The cellular 68,000-MR protein-kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection-implications for translational regulation. J Virol 63 (1989) 2244-2251
237. Black T.L., Barber G.N., and Katze M.G. Degradation of the interferon-induced 68,000-mr protein-kinase by poliovirus requires RNA. J Virol 67 (1993) 791-800
238. Habjan M., Pichlmair A., Elliott R.M., Overby A.K., Glatter T., Gstaiger M., et al. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 83 (2009) 4365-4375
239. Walsh D., Arias C., Perez C., Halladin D., Escandon M., Ueda T., et al. Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells. Mol Cell Biol 28 (2008) 2648-2658
240. Lee D.Y., and Sugden B. The LMP1 oncogene of EBV activates PERK and the unfolded protein response to chive its own synthesis. Blood 111 (2008) 2280-2289
241. Mulvey M., Arias C., and Mohr I. Maintenance of endoplasmic reticulum (ER) homeostasis in herpes simplex virus type 1-infected cells through the association of a viral glycoprotein with PERK, a cellular ER stress sensor. J Virol 81 (2007) 3377-3390
242. Mulvey M., Arias C., and Mohr I. Resistance of mRNA translation to acute endoplasmic reticulum stress-inducing agents in herpes simplex virus type 1-infected cells requires multiple virus-encoded functions. J Virol 80 (2006) 7354-7363
243. Pavio N., Romano P.R., Graczyk T.M., Feinstone S.M., and Taylor D.R. Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2 alpha kinase PERK. J Virol 77 (2003) 3578-3585
244. Yin Q., McBride J., Fewell C., Lacey M., Wang X., Lin Z., et al. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 82 (2008) 5295-5306
245. Harding H.P., Calfon M., Urano F., Novoa I., and Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 18 (2002) 575-599
246. Isler J.A., Maguire T.G., and Alwine J.C. Production of infectious human cytomegalovirus virions is inhibited by drugs that disrupt calcium homeostasis in the endoplasmic reticulum. J Virol 79 (2005) 15388-15397
247. Isler J.A., Skalet A.H., and Alwine J.C. Human cytomegalovirus infection activates and regulates the unfolded protein response. J Virol 79 (2005) 6890-6899